| Code | 7795D | ||||||||||
| MA number | EU/1/21/1550/001 | ||||||||||
| Product Form: | tbl flm 14x(2x2 mg+2x3 mg+2x4 mg+1x5 mg+1x6 mg+1x7 mg+1x8 mg+1x9 mg+3x10 mg) (blis.OPA/alu/PE+DES/PET/alu/PE) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | LABORATOIRES JUVISE PHARMACEUTICALS, France | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 19.05.2021 |
| Validity: | 19.05.2026 |
| SmPC + PL: |
|
| Dokument: |
|
| Dokument: |
|
| Dokument: |
|
| Safety feature | Yes |
| Data update: | 14.07.2023 |